![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eden Research Plc | LSE:EDEN | London | Ordinary Share | GB0001646941 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.45 | 4.30 | 4.60 | 4.45 | 4.45 | 4.45 | 343,084 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 1.83M | -2.24M | -0.0042 | -10.60 | 23.73M |
Date | Subject | Author | Discuss |
---|---|---|---|
03/12/2023 09:28 | Behave! I’m nothing to do with him nor the other idiot you are arguing with. | ![]() kittybiscuits | |
03/12/2023 00:37 | Shut up megabozzo, another alias of yours! | dyslexicsvoices | |
03/12/2023 00:18 | You’ve been wrong before and yet again you are wrong now. | ![]() kittybiscuits | |
01/12/2023 22:15 | It looks like something has triggered Dopey (Filtered). | ![]() weyweyumfozo | |
01/12/2023 20:33 | Bluebelle 1 Dec '23 - 14:42 - 15868 > EDEN remains the company of tomorrow - and always will be. ABSOLUTELY. Unfortunately, far too subtle for these cuckingfunts.... ;D And they prefer to have their ears tickled by paid ramping liars like the appropriately named "Tricky", whose stream of deception and half-truths are enough to tell the sentient that his only stake is in perpetuating the scammerations.... ======= Investingisatrickyga > That may or may not be so Quite. To resolve any ambiguity, I hope that your last moments with us are very, very painful. Your lack of ANY conscience or remorse for all those whose lives you've ruined with your "views" and "unbiased advice" (I almost choken tapping that out) has richly earned such a conclusion. I will go away and "prey" for the desired outcome. | ![]() neutralpov | |
01/12/2023 18:19 | I think the market might start to discount the larger numbers when the numbers become middling | ![]() alchemy | |
01/12/2023 17:29 | >Thus, Eden's role as I see it, is to facilitate the distributors with what they need for farmers and ensure it has a strong regulatory footprint and label. Good point. With every label extension sought and approved the job of the distributors gets easier and the market gets larger, but I still think to get the sales the size of those quoted in the video is quite some time away. However: the road ahead certainly looks considerably brighter than it has in recent years. | ![]() kittybiscuits | |
01/12/2023 16:55 | Your right .Perhaps they can visit the distributors while they're skiing this year and into February. | ![]() chrischas | |
01/12/2023 16:16 | KittyBiscuits That may or may not be so. However, Eden doesn't sell to the end user, the distributor does. Thus, Eden's role as I see it, is to facilitate the distributors with what they need for farmers and ensure it has a strong regulatory footprint and label. | ![]() investingisatrickygame | |
01/12/2023 15:44 | While I fully support and agree with your comments Investigating the timeline for that to occur could easily be another 5+ years | ![]() kittybiscuits | |
01/12/2023 15:10 | Investors ought to focus on the immediate knowns in my opinion Mevalone California Ecovelex EUA in, hopefully, Italy Insecticide distributor and regulatory submissions And what will then follow is label extensions and new territory regulatory submissions for what will be their 4 products. This is the immediate information that is coming the way of investors. This is where the Placing funds will be used to execute that strategy. This is how Eden's footprint will grow enabling distributors to deliver on sales. Yesterday Eden quoted $€ 35-40 million each for Ecovelex and the insecticide per annum. Add in Mevalone & Cedroz and maybe a surprise with Sustaine as they also discussed. You can easily see $€90-100 million turnover per annum in due course with no other product developments. But as Eden has said in the Placing RNS, insecticide label extensions and seeds too, so we can reasonably assume if Eden and their partners estimations come true, that $/€100 million per annum turnover will be exceeded and with a very healthy margin. | ![]() investingisatrickygame | |
01/12/2023 15:08 | Yes to the first part; the second is obviously where you pays yer money and takes yer risk. High risk to be sure. | ![]() brucie5 | |
01/12/2023 14:42 | EDEN remains the company of tomorrow - and always will be. | ![]() bluebelle | |
01/12/2023 14:09 | Supersonico squawked: "I am suing Pfizer for misrepresenting Covid" :P And this is the conspiracy nutter upon whose words you mugwumpfs hang! ;D and ROTFL | ![]() neutralpov | |
01/12/2023 13:30 | Thanks Super, I have started watching this and fully intend to finish, in due course. My feeling is that while this share is very much out of my general comfort zone at this time in my life, it is certainly worth watching, given the prospect of its various technologies and alliances being gradually rolled out across global territories. Ideally this should be reflected in sales, which will need to grow like the snowball, or rise like the hockey stick, whichever metaphor one prefers. The absence of such meaningful sales, let alone profitability, is the main shadow that has haunted its credibility; hence my very modest involvement. I would be nice if someone like Attyg could do one of his summaries for us as we head into the New Year, of how the various prospects and permissions stack up - the simpler the better afaic. I made copious notes back in the day when I took quite a large position, but became disillusioned. That sense of suspicion has not altogether gone away, give how long the promises of a bright new dawn have been delayed over many years. So it may well be that my small resumed interest now is mainly a case of hope over experience. Though is also prompted somewhat by the chart, which seems to be bottoming; and should it repeat what it did in June, I would be very tempted to exit with a two/three bagger, rather than wait for a fortune. Weakling that I am. I have taken a similar position in TERN for much the same reasons. Kind regards, B5. | ![]() brucie5 | |
30/11/2023 23:17 | Eden Research plc (OTCQB: EDNSF | AIM: EDEN): Virtual Investor Conferences | ![]() supersonico | |
30/11/2023 21:45 | Yes I did see the emphasis on ETAnd yes it was an event for the mid/term I imagine. Hence my bsck to patience. Optimistic patience.Atb | ![]() alchemy | |
30/11/2023 20:10 | Canary told you so... Attorney General Ken Paxton @KenPaxtonTX BREAKING:🚨 I am suing Pfizer for misrepresenting Covid-19 vaccine efficacy and conspiring to censor public discourse. | ![]() supersonico | |
30/11/2023 17:38 | Played golf today on frozen ground but the sun was out.Put some seeds before I played. No seeds or bread crumbs when I came back. Must have been hoovered up by the 2 fat pigeons that don't get out and sit idly about | ![]() chrischas | |
30/11/2023 16:55 | Alchemy Perhaps because their primary audience will have been in the US. | ![]() investingisatrickygame |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions